Teizo Yoshimura

机构：Frederick National Laboratory for Cancer Research · ORCID：0000-0002-3853-2075

发表论文 543 篇 · 总被引 21728 次 · h-index 79

代表论文

• The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis (2023 · Cellular and Molecular Immunology · 被引 126)
• A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function (2021 · Kidney International · 被引 95)
• New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine (2023 · Cellular and Molecular Immunology · 被引 79)
• The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases (2021 · Frontiers in Bioscience-Landmark · 被引 38)
• SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells (2023 · International Journal of Molecular Sciences · 被引 35)
• Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer (2022 · Breast Cancer Research · 被引 22)